New York's TEXAS Act to Address Life Insurance Premium Disparities

A New York State senator, James Skoufis, has expressed concern about potentially higher life insurance premiums for New Yorkers due to insurers' use of national mortality data, which incorporates populations with shorter life expectancies, such as those in Texas. To address this, Skoufis has introduced the Terminate Excessive Cross-state Actuarial Subsidization Act (TEXAS Act), proposing that insurers utilize state-specific mortality data for setting rates instead of relying on national averages.

In a recent op-ed, Skoufis emphasized the potential financial burden on New Yorkers due to this practice, describing it as a subsidy to states with lower life expectancy. He referenced the Centers for Disease Control and Prevention's (CDC) findings that life expectancy varies significantly across the United States, with an eight-year discrepancy between states. New York's life expectancy of 79.6 years places it among the highest in the nation.

Skoufis attributes New York's longer life expectancy to substantial investments in public health and social services, contrasting with certain Southern states' policy decisions that contribute to poorer health outcomes. This disparity highlights unequal health insurance coverage, with Texas having a higher percentage of uninsured adults compared to New York, further complicating insurance underwriting dynamics.

Although New York boasts higher life expectancy rates, it remains one of the most expensive states for life insurance. Industry experts suggest that while national pricing models often overlook state-level mortality differences, various factors like age, health status, lifestyle, and medical history play a significant role in determining life insurance premiums. These factors might overshadow the impact of mortality tables.

Rob Hoyt, a professor of Risk Management and Insurance, points out that insurers consider numerous personal health and lifestyle factors, which account for state-to-state life expectancy differences. Meanwhile, actuary Mary Pat Campbell questions whether state-specific data would significantly influence pricing changes, given the unique mortality profiles of individual purchasers compared to the general population.

While Skoufis aims to align life insurance pricing more closely with geographic health outcomes, experts speculate on potential challenges such as increased regulatory compliance and administrative costs, which could offset any savings. The proposed TEXAS Act has been referred to committee, its future contingent on legislative acceptance of Skoufis' arguments regarding risk pricing based on state health statistics.